DK0979652T3 - Helbredende præparat til intraokulær hypertension eller glaukom - Google Patents

Helbredende præparat til intraokulær hypertension eller glaukom

Info

Publication number
DK0979652T3
DK0979652T3 DK98945530T DK98945530T DK0979652T3 DK 0979652 T3 DK0979652 T3 DK 0979652T3 DK 98945530 T DK98945530 T DK 98945530T DK 98945530 T DK98945530 T DK 98945530T DK 0979652 T3 DK0979652 T3 DK 0979652T3
Authority
DK
Denmark
Prior art keywords
glaucoma
intraocular hypertension
healing preparation
healing
preparation
Prior art date
Application number
DK98945530T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DK0979652T3 publication Critical patent/DK0979652T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98945530T 1997-10-13 1998-09-30 Helbredende præparat til intraokulær hypertension eller glaukom DK0979652T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27854097 1997-10-13

Publications (1)

Publication Number Publication Date
DK0979652T3 true DK0979652T3 (da) 2006-09-11

Family

ID=17598695

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98945530T DK0979652T3 (da) 1997-10-13 1998-09-30 Helbredende præparat til intraokulær hypertension eller glaukom

Country Status (8)

Country Link
US (1) US6329426B1 (da)
EP (1) EP0979652B1 (da)
AT (1) ATE326972T1 (da)
CA (1) CA2274708A1 (da)
DE (1) DE69834638T2 (da)
DK (1) DK0979652T3 (da)
ES (1) ES2265166T3 (da)
WO (1) WO1999018969A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356912C (en) * 1998-12-25 2009-02-24 Ryuji Ueno Pharmaceutical compositions for the treatment of ocular hypertension or glaucoma
AU2002243795A1 (en) * 2001-01-30 2002-08-12 Pharmaceutical Research Corporation Use of prostaglandin analogs for treatment of cardiac conditions
US20060264353A1 (en) * 2002-03-21 2006-11-23 Maxey Kirk M Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma
US20020168424A1 (en) * 2002-07-31 2002-11-14 Dr. Mohsen Shahinpoor Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma
US6864282B2 (en) 2002-08-05 2005-03-08 Allergan, Inc. 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
US7320871B2 (en) * 2003-07-14 2008-01-22 Allergan, Inc. Human prostaglandin FP receptor variants and methods of using same
WO2007105691A1 (ja) * 2006-03-13 2007-09-20 R-Tech Ueno, Ltd. 水性組成物
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
WO2017089980A1 (en) * 2015-11-26 2017-06-01 Cadila Healthcare Limited Dual ppar modulators for the treatment of diabetic retinopathy and diabetic eye diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209939B (en) 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
DE68929435T2 (de) * 1988-09-06 2003-07-17 Pharmacia Ab, Stockholm Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension
GB8916944D0 (en) 1989-07-25 1989-09-13 Ici Plc Composite particle dispersions
PT561073E (pt) * 1992-03-19 2002-04-29 R Tech Ueno Ltd Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico
AU665287B2 (en) * 1992-12-21 1995-12-21 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop

Also Published As

Publication number Publication date
HK1024170A1 (en) 2000-10-05
CA2274708A1 (en) 1999-04-22
EP0979652B1 (en) 2006-05-24
US6329426B1 (en) 2001-12-11
DE69834638T2 (de) 2007-05-10
EP0979652A4 (en) 2003-05-14
ES2265166T3 (es) 2007-02-01
DE69834638D1 (de) 2006-06-29
EP0979652A1 (en) 2000-02-16
WO1999018969A1 (en) 1999-04-22
ATE326972T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
DK1514548T3 (da) Topisk ophthalmisk fluprostenol-præparat til behandling af glaukom og okulær hypertension
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
DK112190A (da) Prostaglandinderivater til behandling af glaukom eller foroeget okulaert tryk
AU1709699A (en) 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
NO975962L (no) Legemiddelpreparat som omfatter albumin som aktiv bestanddel
DE69834638D1 (de) Heilende zusammensetzung für intraokulare hypertension oder glaukom
AU5355498A (en) 15-fluoro prostaglandins as ocular hypotensives
WO1998021182A3 (en) Use of cis-δ4 analogs of prostaglandins as ocular hypotensives
DE3578584D1 (de) Therapeutische und vorbeugende ophthalmische loesung fuer intraokulaere hypertension und glaukoma.
ATE216889T1 (de) Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE289198T1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
EP1142576A4 (en) MEDICINAL COMPOSITION FOR TREATING THE INCREASED EYE PRESSURE OR GLAUCOMA